Long-term cognitive impairments in adult rats treated neonatally with beta-N-Methylamino-L-Alanine
about
Maternal transfer of the cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) via milk to suckling offspringIntracellular fibril formation, calcification, and enrichment of chaperones, cytoskeletal, and intermediate filament proteins in the adult hippocampus CA1 following neonatal exposure to the nonprotein amino acid BMAASearching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeQuality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA)Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampusHigh resolution metabolite imaging in the hippocampus following neonatal exposure to the environmental toxin BMAA using ToF-SIMSTransfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposureIncreased anxiety-like behavior but no cognitive impairments in adult rats exposed to constant light conditions during perinatal developmentMALDI imaging delineates hippocampal glycosphingolipid changes associated with neurotoxin induced proteopathy following neonatal BMAA exposure.Probing the lipid chemistry of neurotoxin-induced hippocampal lesions using multimodal imaging mass spectrometryA critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.Imaging mass spectrometry in drug development and toxicologyEnvironmental neurotoxin interaction with proteins: Dose-dependent increase of free and protein-associated BMAA (β-N-methylamino-L-alanine) in neonatal rat brain.β-N-Methylamino-L-alanine (BMAA) perturbs alanine, aspartate and glutamate metabolism pathways in human neuroblastoma cells as determined by metabolic profiling.Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar ratsΒ-N-Methylamino-L-Alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats.Perinatal Exposure to the Cyanotoxin β-N-Méthylamino-L-Alanine (BMAA) Results in Long-Lasting Behavioral Changes in Offspring-Potential Involvement of DNA Damage and Oxidative Stress.A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.Repeated five-day administration of L-BMAA, microcystin-LR, or as mixture, in adult C57BL/6 mice - lack of adverse cognitive effects.Detection of the Cyanotoxins L-BMAA Uptake and Accumulation in Primary Neurons and Astrocytes.Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis.
P2860
Q21559548-836271B8-EC9A-4344-B4E4-490F148FD8EEQ28239546-6DA574C1-87DF-4696-AD82-003049456326Q28393837-F29CAA8C-1D65-44FC-99B1-80708036FBD5Q30444494-C6F7F23A-38EF-4CA6-B6D6-6CBEAF1C7281Q30460930-6415DFE6-BC5B-4137-A4B2-ABF037575355Q33918172-53211564-DE37-4A6B-965C-AB61EDF2FECEQ33927137-0C85DA7B-F328-4730-A6CA-1DF8B45A6D13Q34311170-8A95FD5B-CADB-4544-BB5D-61D468AFAB93Q36221110-055E0213-B3D2-49E0-9EB5-4DE001F42D18Q38616918-74B1FA58-C5C1-45D6-8AB5-BD560E013D6DQ38734183-106BEC7F-7683-4601-A3EA-76E45BFEF69EQ39033781-59EB3326-1779-4F20-8AB4-9C36A2EE1927Q41789221-DC6B986E-5E93-485A-9841-61D0D5860372Q41874642-B1DF6005-7FD5-472C-AF56-EB905862D8BEQ42034211-40DE7C8A-3E15-49AA-9CF9-50CBBFDC1958Q47244005-07B2F1EC-19E4-4C1C-9D02-FC777E670FEBQ47648858-E51BCA34-6610-4234-98DA-66D7D579E355Q47891276-F8D42858-13FC-48F2-8821-74E61E031706Q48112588-BF3691FD-934A-42A1-984F-0BF482FBB47CQ48134620-4DF4CE4A-C4F4-40F6-A03F-BB5EACA053F9Q48181882-4965E4D1-10D1-4028-9091-49029F2F187EQ55263095-05ED5182-E9BA-46FC-AC2D-A176C6DEB045
P2860
Long-term cognitive impairments in adult rats treated neonatally with beta-N-Methylamino-L-Alanine
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@ast
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@en
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@nl
type
label
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@ast
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@en
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@nl
prefLabel
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@ast
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@en
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@nl
P2860
P356
P1476
Long-term cognitive impairment ...... h beta-N-Methylamino-L-Alanine
@en
P2093
Erika Roman
Oskar Karlsson
P2860
P304
P356
10.1093/TOXSCI/KFP196
P407
P577
2009-11-01T00:00:00Z